PAR 7.50% 21.5¢ paradigm biopharmaceuticals limited..

Where we at?, page-622

  1. 686 Posts.
    lightbulb Created with Sketch. 129
    You sound like you know more about this scene than I, but I would be shocked if, after all the talk of avoiding a CR, and with the new skill sets on board, they don't manage to seal some sort of deal to see us through. Particularly once there is the nod from FDA and or TGA. If they can't raise the money at that point, we might as well put my eight-year-old grandson in charge. He can negotiate blood out of a stone.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.